clinical trial · NCT07455084
A Study to Detect the Radioactivity of 14C-SEP-380135 in Urine and Feces in Healthy Male Adults
Otsuka Pharmaceutical Development & Commercialization, Inc.·phase1·not yet recruiting·n = 8
Schizophrenia14C-SEP-380135
brief summary
The purpose of the present trial is to obtain information on the absorption, distribution, metabolism, excretion and pharmacokinetics (PK) of 14C-SEP-380135 and its metabolites following a single oral dose.
started
Mar 20, 2026
primary completion
Apr 10, 2026
completion
May 3, 2026
last updated
Mar 6, 2026
official title
A Phase 1 Trial to Assess the Mass Balance and Pharmacokinetics of a Single Oral Administration of 14C-SEP-380135 in Healthy Male Adults
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol